MXPA03003246A - Derivados de indolina y su uso como ligandos del receptor 5-ht2. - Google Patents
Derivados de indolina y su uso como ligandos del receptor 5-ht2.Info
- Publication number
- MXPA03003246A MXPA03003246A MXPA03003246A MXPA03003246A MXPA03003246A MX PA03003246 A MXPA03003246 A MX PA03003246A MX PA03003246 A MXPA03003246 A MX PA03003246A MX PA03003246 A MXPA03003246 A MX PA03003246A MX PA03003246 A MXPA03003246 A MX PA03003246A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor ligands
- indoline derivatives
- indoline
- derivatives
- ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00122539 | 2000-10-16 | ||
PCT/EP2001/011814 WO2002044152A1 (en) | 2000-10-16 | 2001-10-12 | Indoline derivatives and their use as 5-ht2 receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03003246A true MXPA03003246A (es) | 2003-06-06 |
Family
ID=8170101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03003246A MXPA03003246A (es) | 2000-10-16 | 2001-10-12 | Derivados de indolina y su uso como ligandos del receptor 5-ht2. |
Country Status (15)
Country | Link |
---|---|
US (1) | US6479534B1 (es) |
EP (1) | EP1328515B1 (es) |
JP (1) | JP4047723B2 (es) |
KR (1) | KR100545435B1 (es) |
CN (1) | CN100334076C (es) |
AR (1) | AR038762A1 (es) |
AT (1) | ATE403647T1 (es) |
AU (2) | AU2002221670B2 (es) |
BR (1) | BR0114708A (es) |
CA (1) | CA2422698C (es) |
DE (1) | DE60135239D1 (es) |
ES (1) | ES2311563T3 (es) |
MX (1) | MXPA03003246A (es) |
WO (1) | WO2002044152A1 (es) |
ZA (1) | ZA200302516B (es) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ536664A (en) | 2002-06-19 | 2007-07-27 | Biovitrum Ab | Piperazinylpyrazine derivative compounds, their use and preparation |
US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
WO2004063156A1 (en) * | 2003-01-08 | 2004-07-29 | Biovitrum Ab | Novel indole derivates as fabp-4 inhibitors |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
CA2551037A1 (en) | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | Novel piperidine derivative |
US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
US7081696B2 (en) | 2004-08-12 | 2006-07-25 | Exro Technologies Inc. | Polyphasic multi-coil generator |
EP1792629A4 (en) | 2004-08-25 | 2010-08-25 | Takeda Pharmaceutical | PREVENTIVE / REMEDY AGENTS FOR INCONTINENCE OF STRESS AND SELECETING METHOD THEREOF |
JP4926069B2 (ja) | 2004-11-01 | 2012-05-09 | アミリン・ファーマシューティカルズ,インコーポレイテッド | 肥満ならびに肥満関連疾患および障害の治療方法 |
US7297704B2 (en) | 2005-02-17 | 2007-11-20 | Wyeth | Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
US8138206B2 (en) | 2005-05-30 | 2012-03-20 | Msd. K.K. | Piperidine derivative |
WO2007018248A1 (ja) | 2005-08-10 | 2007-02-15 | Banyu Pharmaceutical Co., Ltd. | ピリドン化合物 |
BRPI0614649A2 (pt) | 2005-08-11 | 2011-04-12 | Amylin Pharmaceuticals Inc | polipeptìdeos hìbridos com propriedades selecionáveis |
AU2006279680B2 (en) | 2005-08-11 | 2012-12-06 | Amylin Pharmaceuticals, Llc | Hybrid polypeptides with selectable properties |
DE602006017712D1 (de) | 2005-08-24 | 2010-12-02 | Banyu Pharma Co Ltd | Phenylpyridonderivat |
JPWO2007029847A1 (ja) | 2005-09-07 | 2009-03-19 | 萬有製薬株式会社 | 二環性芳香族置換ピリドン誘導体 |
WO2007041052A2 (en) | 2005-09-29 | 2007-04-12 | Merck & Co., Inc. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
KR20080059233A (ko) | 2005-10-21 | 2008-06-26 | 노파르티스 아게 | 레닌 억제제, 및 항이상지질혈증제 및/또는 항비만제의조합물 |
EP1944301A4 (en) | 2005-10-27 | 2012-01-04 | Msd Kk | NEW BENZOXATHIIN DERIVATIVES |
ES2381205T3 (es) | 2005-11-10 | 2012-05-24 | Msd K.K. | Derivado espiro aza-sustituido |
EP2742936A1 (en) | 2006-05-16 | 2014-06-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
CN101501963B (zh) | 2006-06-08 | 2012-06-13 | Exro技术公司 | 多相多线圈发电机 |
EP2698157B1 (en) | 2006-09-22 | 2015-05-20 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
AU2007301126A1 (en) | 2006-09-28 | 2008-04-03 | Banyu Pharmaceutical Co., Ltd. | Diaryl ketimine derivative |
WO2008039087A2 (en) * | 2006-09-29 | 2008-04-03 | Auckland Uniservices Limited | Indoline derivatives and uses thereof |
AR063373A1 (es) * | 2006-10-24 | 2009-01-21 | Wyeth Corp | Derivados de benzodioxano y sus usos |
BRPI0806774A2 (pt) | 2007-01-16 | 2011-09-13 | Ipintl Llc | composição para tratamento de sìndrome metabólica |
AU2008233662B2 (en) | 2007-04-02 | 2012-08-23 | Msd K.K. | Indoledione derivative |
CA2688161C (en) | 2007-06-04 | 2020-10-20 | Kunwar Shailubhai | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
JP5520051B2 (ja) | 2007-11-15 | 2014-06-11 | 武田薬品工業株式会社 | 縮合ピリジン誘導体およびその用途 |
EP2264026A4 (en) | 2008-03-06 | 2012-03-28 | Msd Kk | ALKYLAMINOPYRIDINE DERIVATIVE |
JPWO2009119726A1 (ja) | 2008-03-28 | 2011-07-28 | Msd株式会社 | メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体 |
CA2666036C (en) | 2008-05-16 | 2017-09-12 | Chien-Hung Chen | Novel compositions and methods for treating hyperproliferative diseases |
AU2009261248A1 (en) | 2008-06-19 | 2009-12-23 | Banyu Pharmaceutical Co., Ltd. | Spirodiamine-diarylketoxime derivative |
JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
US20110124674A1 (en) | 2008-07-30 | 2011-05-26 | Hiroyuki Kishino | 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
MX2011004258A (es) | 2008-10-22 | 2011-06-01 | Merck Sharp & Dohme | Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos. |
JP5635991B2 (ja) | 2008-10-30 | 2014-12-03 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | イソニコチンアミドオレキシン受容体アンタゴニスト |
JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
EP2379547A1 (en) | 2008-12-16 | 2011-10-26 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
AU2011218830B2 (en) | 2010-02-25 | 2014-07-24 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
EP3243385B1 (en) | 2011-02-25 | 2021-01-13 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
WO2012118972A2 (en) | 2011-03-01 | 2012-09-07 | Synegy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
AR088352A1 (es) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina |
AU2013296470B2 (en) | 2012-08-02 | 2016-03-17 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CN105764916B (zh) | 2013-06-05 | 2021-05-18 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
MX2017002610A (es) | 2014-08-29 | 2017-10-11 | Tes Pharma S R L | INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA. |
AR109950A1 (es) | 2016-10-14 | 2019-02-06 | Tes Pharma S R L | INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA |
MX2019012806A (es) | 2017-05-23 | 2020-01-20 | Dpm Tech Inc | Configuracion de sistema de control de bobina variable, aparato y metodo. |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
TW202033516A (zh) | 2018-11-20 | 2020-09-16 | 義大利商Tes製藥(股份)責任有限公司 | α-胺基-β-羧基己二烯二酸半醛去羧酶之抑制劑 |
WO2020167706A1 (en) | 2019-02-13 | 2020-08-20 | Merck Sharp & Dohme Corp. | 5-alkyl pyrrolidine orexin receptor agonists |
CA3137550C (en) | 2019-04-23 | 2024-05-21 | Dpm Technologies Inc. | Fault tolerant rotating electric machine |
EP4010314B1 (en) | 2019-08-08 | 2024-02-28 | Merck Sharp & Dohme LLC | Heteroaryl pyrrolidine and piperidine orexin receptor agonists |
EP4200295A1 (en) | 2020-08-18 | 2023-06-28 | Merck Sharp & Dohme LLC | Bicycloheptane pyrrolidine orexin receptor agonists |
EP4315556A1 (en) | 2021-05-04 | 2024-02-07 | Exro Technologies Inc. | Battery control systems and methods |
US11967913B2 (en) | 2021-05-13 | 2024-04-23 | Exro Technologies Inc. | Method and apparatus to drive coils of a multiphase electric machine |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2541211A (en) | 1948-10-15 | 1951-02-13 | Searle & Co | Tertiary-aminoalkyl-tetrahydrocarbazoles |
US2687414A (en) | 1948-11-26 | 1954-08-24 | Searle & Co | Method for producing aromatic aminoalkyl amines |
DE930988C (de) | 1953-01-01 | 1955-07-28 | Bayer Ag | Verfahren zur Herstellung von basisch alkylierten Tetrahydrocarbazolen oder Indolen |
US3142678A (en) | 1962-01-09 | 1964-07-28 | American Home Prod | Amino substituted penthienoindoles |
US3663567A (en) * | 1970-12-04 | 1972-05-16 | Sandoz Ag | N-substituted cycloalkanoindoles |
GB1418703A (en) * | 1973-06-02 | 1975-12-24 | Pfizer Ltd | 3-alkyl-9-substituted-1,2,3,4-tetrahydrocarbazoles |
GB1432649A (es) | 1973-09-07 | 1976-04-22 | Ici Ltd | |
CA1247547A (en) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
CA1270837A (en) | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
CA1328881C (en) | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
CA2035972C (en) | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
US5274143A (en) | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
TW270114B (es) * | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
TW334423B (en) * | 1993-10-22 | 1998-06-21 | Hoffmann La Roche | Tricyclic 1-aminoethylpyrrole-derivatives |
AU5343298A (en) | 1997-01-13 | 1998-08-03 | Yamanouchi Pharmaceutical Co., Ltd. | 5-ht2c receptor agonists and aminoalkylindazole derivatives |
US6004996A (en) | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
KR20010079636A (ko) | 1998-08-14 | 2001-08-22 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 라이페이즈 저해제 및 키토산을 포함하는 약학 조성물 |
WO2000009122A1 (en) | 1998-08-14 | 2000-02-24 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions containing lipase inhibitors |
GB9918962D0 (en) * | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxii |
-
2001
- 2001-10-12 DE DE60135239T patent/DE60135239D1/de not_active Expired - Lifetime
- 2001-10-12 JP JP2002546522A patent/JP4047723B2/ja not_active Expired - Fee Related
- 2001-10-12 WO PCT/EP2001/011814 patent/WO2002044152A1/en active IP Right Grant
- 2001-10-12 AT AT01998144T patent/ATE403647T1/de not_active IP Right Cessation
- 2001-10-12 BR BR0114708-0A patent/BR0114708A/pt not_active IP Right Cessation
- 2001-10-12 MX MXPA03003246A patent/MXPA03003246A/es active IP Right Grant
- 2001-10-12 CA CA002422698A patent/CA2422698C/en not_active Expired - Fee Related
- 2001-10-12 AR ARP010104806A patent/AR038762A1/es unknown
- 2001-10-12 ES ES01998144T patent/ES2311563T3/es not_active Expired - Lifetime
- 2001-10-12 AU AU2002221670A patent/AU2002221670B2/en not_active Ceased
- 2001-10-12 KR KR1020037005300A patent/KR100545435B1/ko not_active IP Right Cessation
- 2001-10-12 EP EP01998144A patent/EP1328515B1/en not_active Expired - Lifetime
- 2001-10-12 CN CNB018174434A patent/CN100334076C/zh not_active Expired - Fee Related
- 2001-10-12 AU AU2167002A patent/AU2167002A/xx active Pending
- 2001-10-15 US US09/977,783 patent/US6479534B1/en not_active Expired - Fee Related
-
2003
- 2003-03-31 ZA ZA200302516A patent/ZA200302516B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2004527467A (ja) | 2004-09-09 |
BR0114708A (pt) | 2003-07-01 |
US6479534B1 (en) | 2002-11-12 |
KR20030048437A (ko) | 2003-06-19 |
US20020183349A1 (en) | 2002-12-05 |
DE60135239D1 (de) | 2008-09-18 |
JP4047723B2 (ja) | 2008-02-13 |
WO2002044152A1 (en) | 2002-06-06 |
ES2311563T3 (es) | 2009-02-16 |
AU2167002A (en) | 2002-06-11 |
CN1630636A (zh) | 2005-06-22 |
CA2422698A1 (en) | 2002-06-06 |
AU2002221670B2 (en) | 2006-11-02 |
EP1328515B1 (en) | 2008-08-06 |
ATE403647T1 (de) | 2008-08-15 |
ZA200302516B (en) | 2004-06-30 |
CA2422698C (en) | 2009-12-15 |
AR038762A1 (es) | 2005-01-26 |
EP1328515A1 (en) | 2003-07-23 |
CN100334076C (zh) | 2007-08-29 |
KR100545435B1 (ko) | 2006-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03003246A (es) | Derivados de indolina y su uso como ligandos del receptor 5-ht2. | |
MXPA03005915A (es) | Derivados de indol y su uso como ligandos receptores de 5-ht2b y 5-ht2c. | |
HK1050004A1 (en) | Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands. | |
MXPA03005648A (es) | Derivados de carbazol y su uso, como ligandos de receptor del neuropeptido y5. | |
MXPA02001508A (es) | Derivados de arilmetil-carbonilamino-tiazol y sus usos como agentes antitumorales. | |
AU2001246671A1 (en) | Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands | |
PL353969A1 (en) | Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands | |
ZA200201494B (en) | Benzodiazepin derivatives, the production and use thereof. | |
ZA200000894B (en) | 4-Phenyl-pyridine derivatives. | |
ZA200201055B (en) | Amino-triazolopyridine derivatives. | |
MXPA02008801A (es) | Derivados de indol, proceso para la preparacion de los mismos y su uso. | |
HK1048999A1 (zh) | 氮雜䓬吲衍生物,它們的製備和應用 | |
MXPA03003039A (es) | Derivados de indola y bencimidazola como moduladores del receptor crf. | |
ZA200110218B (en) | Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands. | |
ZA200109595B (en) | 13-methyl-erythromycin derivatives. | |
HK1046411A1 (en) | 5-Phenyl-pyrimidine derivatives. | |
HK1051863A1 (en) | Indol-3-yl derivatives. | |
MXPA03000644A (es) | Nuevos derivados de indol y uso como medicamentos. | |
ZA200001746B (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use. | |
AU8664701A (en) | Oxindole derivatives | |
MXPA01012041A (es) | Derivados de indol. | |
HK1049161A1 (en) | Indole derivatives. | |
ZA200201276B (en) | 3-Amino-2-phenyl-propane derivatives. | |
MXPA01011285A (es) | Derivados de tio-oxindol. | |
ZA200001747B (en) | 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |